江 玲玲

Medicine & Life Sciences

1. Chronic Obstructive Pulmonary Disease 100%
2. Exercise 81%
3. Mechanical Ventilators 72%
4. Lung 69%
5. Artificial Respiration 53%
6. Ventilation 44%
7. Walking 42%
8. Oxygen 42%
9. Positive-Pressure Respiration 37%
10. Respiratory Insufficiency 28%
11. Asthma 27%
12. Pressure 26%
13. Vital Capacity 26%
14. Ventilator-Induced Lung Injury 26%
15. lipoteichoic acid 25%
16. Respiratory Muscles 24%
17. Walk Test 24%
18. Lung Injury 24%
19. Spirometry 23%
20. Dyspnea 22%
21. Bronchiectasis 21%
22. Hypercapnia 21%
23. Rehabilitation 20%
24. Gases 20%
25. Respiratory Function Tests 19%
26. Cannula 18%
27. Cyclooxygenase 2 18%
28. Aziridines 17%
29. Sulfanilamides 17%
30. Quality of Life 17%
31. Weaning 17%
32. Thorax 17%
33. Respiration 17%
34. ErbB Receptors 16%
35. Taiwan 16%
36. Soot 15%
37. Protein Kinase C 15%
38. Muscles 14%
39. Home Care Services 14%
40. Therapeutics 14%
41. Nose 14%
42. Macrophages 14%
43. pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid 14%
44. Heart Failure 14%
45. Carbon Dioxide 13%
46. Anhydrides 13%
47. Randomized Controlled Trials 13%
48. Hypoxia 13%
49. Control Groups 13%
50. Fenoterol 13%